Skip to main content
U.S. flag

An official website of the United States government

MED-COVID-19: Building research infrastructure (Milestone 4.AA)

In Progress

Timeline Start - End

2022 - 2025

Research Implementation Area

Translational Tools, Infrastructure, and Capabilities

AD-Related Dementias Focus

Establish research infrastructure enabling clinical, epidemiological, and basic research studies of COVID-19 impact on AD/ADRD risk and outcomes, prioritizing disproportionally affected populations and clinical trials readiness.

Success Criteria

  • At least one study to establish new or leverage existing clinical cohorts for longitudinal prospective studies to examine the impact of COVID-19 on AD/ADRD risk and outcomes.
  • Leverage existing resources to ensure brain, other biological samples, and standardized AD/ADRD clinical data from persons infected with SARS-CoV-2, including in populations that are disproportionally impacted, are accessible for AD/ADRD research.

Summary of Key Accomplishments

This milestone has just been initiated. Accomplishments are forthcoming.

The key accomplishments summary is current as of November 2022.

Accomplishments/Implementation Activities

Funding Initiatives

Research Programs and Resources

Research Highlights

Relevant Recommendations

Related Milestones

Search all Research Categories

An official website of the National Institutes of Health